17β-Estradiol corrects hemostasis in uremic rats by limiting vascular expression of nitric oxide synthases

American Journal of Physiology - Renal Physiology

Volumn 279, Issue 4 48-4, 2000, Pages

  Noris, Marina ^a,b   Todeschini, Marta ^a   Zappella, Sergio ^a   Bonazzola, Samantha ^a   Zoja, Carla ^a   Corna, Daniela ^a   Gaspari, Flavio ^a   Marchetti, Franco ^a   Aiello, Sistiana ^a   Remuzzi, Giuseppe ^a  

^a OSPEDALI RIUNITI   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Bleeding time; Chronic renal failure; Conjugated estrogens; Endothelium

Indexed keywords

ESTRADIOL; NITRIC OXIDE SYNTHASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRATE; NITRITE; NOS2 PROTEIN, RAT; NOS3 PROTEIN, RAT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BLEEDING TIME; CHRONIC KIDNEY FAILURE; DRUG MECHANISM; ENZYME ACTIVITY; HEMOSTASIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UREMIA; ANIMAL; BLOOD; BLOOD VESSEL; DRUG ANTAGONISM; DRUG EFFECT; ENZYME IMMUNOASSAY; ENZYMOLOGY; METABOLISM; REFERENCE VALUE; SPRAGUE DAWLEY RAT; THORACIC AORTA;

ANIMALS; AORTA, THORACIC; BLEEDING TIME; BLOOD VESSELS; ESTRADIOL; HEMOSTASIS; IMMUNOENZYME TECHNIQUES; MALE; NADPH DEHYDROGENASE; NITRATES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; UREMIA;

EID: 0033712279     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2000.279.4.f626     Document Type: Article

References (67)

1. HMEC-1: Establishment of an immortalized human microvascular endothelial cell line
2. Renal and systemic nitric oxide synthesis in rats with renal mass reduction
3. Estrogen attenuates endothelin-1 production by bovine endothelial ceils via estrogen receptor
4. Nitric oxide in the kidney: Synthesis, localization and function
5. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women
6. Differential effects of low- and high dose estrogen treatments on vascular responses in female rats
7. Renal synthesis of arginine in chronic renal failure: In vivo and in vitro studies in rats with 5/6 nephrectomy
8. Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS
9. Oestrogen binding sites in fresh human aortic tissue
10. 17β-Estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization
11. Estrogen receptor a mediates the non genomic activation of endothelial nitric oxide synthase by estrogen
12. Estrogen-binding sites in endothelial cell cultures
13. Menopause and the risk of coronary heart disease in women
14. Identification of increased nitric oxide biosynthesis during pregnancy in rats
15. Risk of venous thromboembolism in users of hormone replacement therapy
16. Prevention of fatty streak formation of 17 beta-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice
17. Urinary nitrate excretion in relation to murine macrophage activation
18. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids
19. Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo
20. Transcriptional regulation of the human endothelial nitric oxide synthase gene (ECNOS) by estrogen: Evidence for biphasic regulation
21. Estrogen increases endothelial nitric oxide by a receptor-mediated system
22. Physiological concentrations of 17beta-estradiol inhibit the synthesis of nitric oxide synthase in macrophages via a receptor-mediated system
23. Effects of 17beta-estradiol on sympathetic activity and pressor response to phenylephrine in ovariectomized rats
24. Effect of conjugated estrogens on platelet function and prostacyclin generation in CRF
25. The inhibition of arginase by amino acids
26. o-Phthaldialdehyde precolumn derivatization and reversed-phase high-performance liquid chromatography of polypeptide hydrolysates and physiological fluids
27. Suppression of type II collagen-induced arthritis by the endogenous estrogen metabolite 2-methoxyestradiol
28. Effect of 17beta-estradiol on cytokine-induced nitric oxide production in rat isolated aorta
29. 17β-Estradiol attenuates endotoxin-induced excessive nitric oxide production in ovariectomized rats in vivo
30. Diacylglycerol amplifies the induction in vivo of tyrosine aminotransferase and ornithine decarboxylase by glucocorticoid
31. Estrogen's increase transcription of the human endothelial NO synthase gene: Analysis of the transcription factors involved
32. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium
33. Bleeding tendency in uremia
34. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women
35. Conjugated estrogens for the management of bleeding associated with renal failure
36. Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium
37. Conjugated estrogens shorten bleeding time in uraemia: A possible role of serotonin?
38. Nitric oxide: Biosynthesis and biological significance
39. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene
40. Upregulation of endothelial constitutive NOS: A major role in the increased NO production in cirrhotic rats
41. Nitric oxide, cGMP, and hormone regulation of active sodium trensport
42. Molecular mechanisms and therapeutic strategies related to nitric oxide
43. Nitric oxide: Physiology, pathophysiology and pharmacology
44. Estrogens and progestins
45. Nitrotyrosine residues in placenta: Evidence of peroxynitrite formation and action
46. Enhanced nitric oxide synthesis in uremia: Implications for platelet dysfunction and dialysis hypotension
47. Role of heparin as a protective agent following reduction of renal mass
48. The postnatal ontogeny of rat uterine ornithine decarboxylase: Acquisition of a second peak of estrogen-induced enzyme activity
49. Characterization and localization of endothelial nitric oxide synthase by using specific monoclonal antibodies
50. Glucocorticolds inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells
51. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock
52. Role of endothelium-derived nitric oxide in the bleeding tendency of uremia
53. Hematologic consequences of renal failure
54. Effects of female hormones (17beta-estradiol and progesterone) on nitric oxide production by alveolar macrophages in rats
55. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate
56. Oral estrogens decrease bleeding time and improve clinical bleeding in patients with renal failure
57. Bleeding time in uremia: A useful test to assess clinical bleeding
58. Nitric oxide inhibits bafilomycin-sensitive H+-ATPase activity in the rat cortical collecting duct
59. Immunocytochemical localization of distinct isoforms of nitric oxide synthase in the juxtaglomerular apparatus of the normal kidney
60. Organization of the bovine gene encoding the endothelial nitric oxide synthase
61. Dose-effect and pharmacokinetics of estrogens given to correct bleeding time in uremia
62. 17β-Estradiol is the most active component of the conjugated estrogen mixture active on uremic bleeding by a receptor mechanism
63. Nitric oxide synthases: Biochemical and molecular regulation
64. No role for NO in estrogen-mediated vasoprotection?
65. Interleukin-1beta-induced nitric oxide production in rat aortic endothelial cells: Inhibition by estradiol in normal and high-glucose cultures
66. L-arginine, the precursor of nitric oxide, abolishes the effect of estrogens on bleeding time in experimental uremia
67. Prolonged bleeding time and increased vascular prostacyclin in rats with chronic renal failure: Effects of conjugated estrogens